Roche Holding AG (RHHVF)
241.51
-9.28
(-3.70%)
USD |
OTCM |
Apr 24, 14:50
Roche Free Cash Flow: 12.82B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.82B |
| June 30, 2023 | 12.94B |
| December 31, 2022 | 13.75B |
| June 30, 2022 | 18.59B |
| December 31, 2021 | 17.90B |
| June 30, 2021 | 15.52B |
| December 31, 2020 | 12.87B |
| June 30, 2020 | 15.99B |
| December 31, 2019 | 17.59B |
| June 30, 2019 | 14.68B |
| December 31, 2018 | 15.19B |
| June 30, 2018 | 14.19B |
| December 31, 2017 | 14.00B |
| June 30, 2017 | 12.29B |
| December 31, 2016 | 9.957B |
| June 30, 2016 | 10.24B |
| December 31, 2015 | 11.48B |
| June 30, 2015 | 11.53B |
| Date | Value |
|---|---|
| December 31, 2014 | 13.61B |
| June 30, 2014 | 14.86B |
| December 31, 2013 | 14.03B |
| June 30, 2013 | 13.56B |
| December 31, 2012 | 13.50B |
| June 30, 2012 | 11.83B |
| December 31, 2011 | 12.08B |
| June 30, 2011 | 12.94B |
| December 31, 2010 | 11.03B |
| June 30, 2010 | 11.97B |
| December 31, 2009 | 13.06B |
| June 30, 2009 | 10.32B |
| December 31, 2008 | 7.775B |
| June 30, 2008 | 6.615B |
| December 31, 2007 | 6.172B |
| June 30, 2007 | 5.287B |
| December 31, 2006 | 4.988B |
Free Cash Flow Range, Past 5 Years
12.82B
Minimum
Dec 2023
18.59B
Maximum
Jun 2022
15.26B
Average
15.10B
Median
Free Cash Flow Benchmarks
| AC Immune SA | -68.17M |
| CRISPR Therapeutics AG | -272.34M |
| Addex Therapeutics Ltd | -8.908M |
| NLS Pharmaceutics Ltd | -- |
Free Cash Flow Related Metrics
| Free Cash Flow Yield | 6.60% |